Cansu Yanginlar

1.2k total citations
10 papers, 614 citations indexed

About

Cansu Yanginlar is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Cansu Yanginlar has authored 10 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Cansu Yanginlar's work include Complement system in diseases (3 papers), COVID-19 Clinical Research Studies (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Cansu Yanginlar is often cited by papers focused on Complement system in diseases (3 papers), COVID-19 Clinical Research Studies (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Cansu Yanginlar collaborates with scholars based in Netherlands, Germany and United States. Cansu Yanginlar's co-authors include Johan van der Vlag, Luuk B. Hilbrands, Nils Rother, Elmar Pieterse, Colin Logie, Baranca Buijsers, Marissa L. Maciej-Hulme, Quirijn de Mast, Peter Pickkers and Luis E. Muñoz and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Cansu Yanginlar

10 papers receiving 609 citations

Peers

Cansu Yanginlar
Richard T. Amison United Kingdom
Kyung D. Moon United States
Suman Kundu United States
Hema Kothari United States
Rinku Majumder United States
Richard T. Amison United Kingdom
Cansu Yanginlar
Citations per year, relative to Cansu Yanginlar Cansu Yanginlar (= 1×) peers Richard T. Amison

Countries citing papers authored by Cansu Yanginlar

Since Specialization
Citations

This map shows the geographic impact of Cansu Yanginlar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cansu Yanginlar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cansu Yanginlar more than expected).

Fields of papers citing papers by Cansu Yanginlar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cansu Yanginlar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cansu Yanginlar. The network helps show where Cansu Yanginlar may publish in the future.

Co-authorship network of co-authors of Cansu Yanginlar

This figure shows the co-authorship network connecting the top 25 collaborators of Cansu Yanginlar. A scholar is included among the top collaborators of Cansu Yanginlar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cansu Yanginlar. Cansu Yanginlar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yanginlar, Cansu, Nils Rother, Joost H.A. Martens, et al.. (2024). Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus. Journal of Autoimmunity. 149. 103335–103335. 6 indexed citations
2.
Rother, Nils, Cansu Yanginlar, Elmar Pieterse, Luuk B. Hilbrands, & Johan van der Vlag. (2022). Microparticles in Autoimmunity: Cause or Consequence of Disease?. Frontiers in Immunology. 13. 822995–822995. 13 indexed citations
3.
Loeven, Markus A., Marissa L. Maciej-Hulme, Cansu Yanginlar, et al.. (2021). Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies. Frontiers in Immunology. 12. 676662–676662. 9 indexed citations
4.
Buijsers, Baranca, Cansu Yanginlar, Marissa L. Maciej-Hulme, Quirijn de Mast, & Johan van der Vlag. (2020). Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. EBioMedicine. 59. 102969–102969. 104 indexed citations
5.
Rother, Nils, Cansu Yanginlar, Rik G.H. Lindeboom, et al.. (2020). Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. Cell Reports Medicine. 1(9). 100146–100146. 29 indexed citations
6.
Buijsers, Baranca, Cansu Yanginlar, Aline de Nooijer, et al.. (2020). Increased Plasma Heparanase Activity in COVID-19 Patients. Frontiers in Immunology. 11. 575047–575047. 102 indexed citations
7.
Maas, Rutger, Jeroen K. Deegens, Cansu Yanginlar, et al.. (2020). Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis. Nephrology Dialysis Transplantation. 36(2). 247–256. 14 indexed citations
8.
Pieterse, Elmar, Nils Rother, Cansu Yanginlar, et al.. (2018). Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation. Annals of the Rheumatic Diseases. 77(12). 1790–1798. 83 indexed citations
9.
Yanginlar, Cansu & Colin Logie. (2017). HDAC11 is a regulator of diverse immune functions. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1861(1). 54–59. 74 indexed citations
10.
Pieterse, Elmar, Nils Rother, Cansu Yanginlar, Luuk B. Hilbrands, & Johan van der Vlag. (2016). Neutrophils Discriminate between Lipopolysaccharides of Different Bacterial Sources and Selectively Release Neutrophil Extracellular Traps. Frontiers in Immunology. 7. 484–484. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026